Ventana Biotech EBITDA vs. Market Capitalization
| VNTA Stock | USD 0.0004 0.00 0.00% |
For Ventana Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ventana Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ventana Biotech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ventana Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ventana Biotech over time as well as its relative position and ranking within its peers.
Ventana |
Ventana Biotech Market Capitalization vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ventana Biotech's current stock value. Our valuation model uses many indicators to compare Ventana Biotech value to that of its competitors to determine the firm's financial worth. Ventana Biotech is rated first in ebitda category among its peers. It is rated second in market capitalization category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ventana Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ventana Biotech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ventana Market Capitalization vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Ventana Biotech |
| = | (36.71 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Ventana Biotech |
| = | 192.73 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Ventana Market Capitalization vs Competition
Ventana Biotech is rated second in market capitalization category among its peers. Market capitalization of Shell Companies industry is at this time estimated at about 60.15 Million. Ventana Biotech adds roughly 192,731 in market capitalization claiming only tiny portion of equities listed under Shell Companies industry.
Ventana Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ventana Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ventana Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Ventana Biotech's change in net profit over the period of time. It can combine multiple indicators of Ventana Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland. Ventana Biotech is traded on OTC Exchange in the United States.
Ventana Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ventana Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ventana Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ventana Biotech's important profitability drivers and their relationship over time.
Use Ventana Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ventana Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will appreciate offsetting losses from the drop in the long position's value.Ventana Biotech Pair Trading
Ventana Biotech Pair Trading Analysis
The ability to find closely correlated positions to Ventana Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ventana Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ventana Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ventana Biotech to buy it.
The correlation of Ventana Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ventana Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ventana Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ventana Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ventana Biotech position
In addition to having Ventana Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ventana Pink Sheet
To fully project Ventana Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ventana Biotech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ventana Biotech's income statement, its balance sheet, and the statement of cash flows.